• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减重手术的再次手术:谁、什么、哪里和何时?

Revisional bariatric surgery: who, what, where, and when?

机构信息

Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania 17033, USA.

出版信息

Surg Obes Relat Dis. 2010 Nov-Dec;6(6):635-42. doi: 10.1016/j.soard.2010.04.005. Epub 2010 May 4.

DOI:10.1016/j.soard.2010.04.005
PMID:20702147
Abstract

BACKGROUND

Revisional bariatric surgery (RBS) outcomes have been poorly characterized. We compared the RBS and primary bariatric surgery (PBS) outcomes at the Penn State Milton S. Hershey Medical Center in the United States.

METHODS

A total of 72 RBS cases from 2000 to 2007 were reviewed and grouped by indication: failure of weight loss, gastrojejunal complications, or other. The RBS patients were compared with the 856 PBS patients who underwent Roux-en-Y gastric bypass. The mean follow-up time was 12.6 ± 1.2 months for the RBS group and 16 ± 0.5 months for the PBS group. Weight loss was analyzed as the kilograms lost and patients with ≥ 50% excess body weight loss (EBWL). Outcomes included mortality, leaks, surgical site infections, and length of stay.

RESULTS

The weight loss was 23 ± 2.8 kg after RBS and 41.3 ± 0.7 kg after PBS (P <.05 versus PBS). The post-RBS weight loss varied by surgical indication: failure of weight loss, 27.1 ± 2 kg; gastrojejunal complications, 8.7 ± 3.4 kg; and other 23.5 ± 10.6 kg. Also, 29% of the RBS patients had ≥ 50% excess body weight loss (versus the prerevision weight) and 61% (versus the initial weight) compared with 52.7% after PBS. Only age ≤ 50 years was associated with ≥ 50% excess body weight loss after RBS for the failure of weight loss group. No RBS patients died. However, leaks, surgical site infections, and length of stay were increased after RBS.

CONCLUSION

The results of our study have shown that weight loss after RBS varies with the surgical indication and is affected by age >50 years. Although the RBS patients had decreased weight loss and increased complications compared with the PBS patients, ≥ 50% EBWL was achieved by a significant number of RBS patients.

摘要

背景

减重手术的翻修术(RBS)结果描述较差。我们在美国宾夕法尼亚州立大学米尔敦·赫尔希医疗中心比较了 RBS 和原发性减重手术(PBS)的结果。

方法

回顾了 2000 年至 2007 年的 72 例 RBS 病例,并根据指征进行分组:体重减轻失败、胃空肠并发症或其他。将 RBS 患者与接受 Roux-en-Y 胃旁路术的 856 例 PBS 患者进行比较。RBS 组的平均随访时间为 12.6 ± 1.2 个月,PBS 组为 16 ± 0.5 个月。体重减轻分析为减轻的公斤数和体重减轻≥50%的患者(EBWL)。结果包括死亡率、漏诊、手术部位感染和住院时间。

结果

RBS 后体重减轻 23 ± 2.8 公斤,PBS 后体重减轻 41.3 ± 0.7 公斤(P <.05 与 PBS 相比)。RBS 后体重减轻因手术指征而异:体重减轻失败,27.1 ± 2 公斤;胃空肠并发症,8.7 ± 3.4 公斤;其他 23.5 ± 10.6 公斤。此外,29%的 RBS 患者(与术前体重相比)和 61%的 RBS 患者(与初始体重相比)有≥50%的 EBWL,而 PBS 后有 52.7%的患者有≥50%的 EBWL。仅年龄≤50 岁与 RBS 后体重减轻失败组的≥50% EBWL 相关。没有 RBS 患者死亡。然而,RBS 后漏诊、手术部位感染和住院时间增加。

结论

我们的研究结果表明,RBS 后的体重减轻因手术指征而异,并受年龄>50 岁的影响。尽管与 PBS 患者相比,RBS 患者的体重减轻减少且并发症增加,但仍有大量 RBS 患者达到了≥50%的 EBWL。

相似文献

1
Revisional bariatric surgery: who, what, where, and when?减重手术的再次手术:谁、什么、哪里和何时?
Surg Obes Relat Dis. 2010 Nov-Dec;6(6):635-42. doi: 10.1016/j.soard.2010.04.005. Epub 2010 May 4.
2
Weight loss outcome of revisional bariatric operations varies according to the primary procedure.减重手术翻修术的减重效果因初次手术方式而异。
Ann Surg. 2008 Aug;248(2):227-32. doi: 10.1097/SLA.0b013e3181820cdf.
3
Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.在一家大型减肥手术中心接受减肥手术的超级肥胖(BMI≥60 kg/m²)患者的短期结局:腹腔镜可调节胃束带术、腹腔镜胃旁路术和开放式管状胃旁路术。
Surg Obes Relat Dis. 2008 May-Jun;4(3):408-15. doi: 10.1016/j.soard.2007.10.013. Epub 2008 Feb 1.
4
Surgical weight loss >65 years old: is it worth the risk?65 岁以上患者的外科减重手术:是否值得冒险?
Surg Obes Relat Dis. 2010 Sep-Oct;6(5):491-6. doi: 10.1016/j.soard.2009.09.020. Epub 2009 Nov 10.
5
Revisional bariatric surgery for failed restrictive procedures.针对限制性手术失败的减重修复手术。
Surg Obes Relat Dis. 2008 Sep-Oct;4(5):581-6. doi: 10.1016/j.soard.2007.10.004. Epub 2007 Dec 11.
6
Revisional bariatric surgery: 13-year experience from a tertiary institution.减重手术翻修:一所三级医疗机构的13年经验
Arch Surg. 2010 Feb;145(2):173-7. doi: 10.1001/archsurg.2009.260.
7
Medical tourism in bariatric surgery.减肥手术的医疗旅游。
Am J Surg. 2010 May;199(5):604-8. doi: 10.1016/j.amjsurg.2010.01.002. Epub 2010 Mar 25.
8
Introduction of laparoscopic bariatric surgery in England: observational population cohort study.英国腹腔镜减重手术介绍:观察性人群队列研究。
BMJ. 2010 Aug 26;341:c4296. doi: 10.1136/bmj.c4296.
9
Laparoscopic revisional surgery after Roux-en-Y gastric bypass and sleeve gastrectomy.腹腔镜再次手术治疗 Roux-en-Y 胃旁路术和袖状胃切除术之后。
Surg Obes Relat Dis. 2010 Sep-Oct;6(5):485-90. doi: 10.1016/j.soard.2009.09.022. Epub 2010 Jan 1.
10
Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients.腹腔镜再次减重手术:27例连续病例的经验
Obes Surg. 2002 Apr;12(2):254-60. doi: 10.1381/096089202762552737.

引用本文的文献

1
Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.胰高血糖素样肽-1受体激动剂在代谢性减重手术后体重复发或临床反应欠佳管理中的疗效与安全性:一项荟萃分析
Obes Surg. 2025 May;35(5):1947-1960. doi: 10.1007/s11695-025-07856-y. Epub 2025 Apr 16.
2
Experiencing Complications After Metabolic and Bariatric Surgeries is a Risk Factor for Postoperative Emergency Department Admissions: a Retrospective Cohort Study.代谢与减重手术后出现并发症是术后急诊入院的一个风险因素:一项回顾性队列研究。
Obes Surg. 2025 Mar;35(3):875-883. doi: 10.1007/s11695-025-07710-1. Epub 2025 Feb 1.
3
Reversal of Roux-en-Y Gastric Bypass: A Multi-Centric Analysis of Indications, Techniques, and Surgical Outcomes.
Roux-en-Y胃旁路术的逆转:适应症、技术及手术结果的多中心分析
Obes Surg. 2025 Feb;35(2):471-480. doi: 10.1007/s11695-024-07650-2. Epub 2025 Jan 16.
4
Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review.辅助性葡萄糖类似物 1 型受体激动剂治疗减重手术后体重减轻不理想:系统评价。
Obes Surg. 2024 May;34(5):1846-1854. doi: 10.1007/s11695-024-07127-2. Epub 2024 Mar 4.
5
Non-response After Gastric Bypass and Sleeve Gastrectomy-the Theoretical Need for Revisional Bariatric Surgery: Results from the Scandinavian Obesity Surgery Registry.胃旁路和袖状胃切除术后无应答 - 再次减重手术的理论需求:来自斯堪的纳维亚肥胖手术登记处的结果。
Obes Surg. 2023 Oct;33(10):2973-2980. doi: 10.1007/s11695-023-06783-0. Epub 2023 Aug 16.
6
Minimally Invasive Revisional Bariatric Surgery in a MBSAQIP Accredited High-Volume Center.在一个获得MBSAQIP认证的高容量中心进行的微创减重修复手术。
Front Surg. 2022 Apr 1;9:880044. doi: 10.3389/fsurg.2022.880044. eCollection 2022.
7
Revisional Roux-en-Y gastric bypass after failed gastric banding: a case-matched study.胃旁路术治疗胃束带术失败后的再次手术:病例对照研究。
Surg Endosc. 2022 Jul;36(7):4815-4820. doi: 10.1007/s00464-021-08825-z. Epub 2021 Oct 27.
8
Outcomes of primary versus revisional robotically assisted laparoscopic Roux-en-Y gastric bypass: a multicenter analysis of ten-year experience.初次与再次机器人辅助腹腔镜 Roux-en-Y 胃旁路术的结果:十年经验的多中心分析。
Surg Endosc. 2021 Oct;35(10):5766-5773. doi: 10.1007/s00464-020-08061-x. Epub 2020 Oct 7.
9
Is Revisional Gastric Bypass as Effective as Primary Gastric Bypass for Weight Loss and Improvement of Comorbidities?再次胃旁路术与初次胃旁路术治疗肥胖及其合并症的效果比较:再次胃旁路术是否同样有效?
Obes Surg. 2020 Apr;30(4):1219-1229. doi: 10.1007/s11695-019-04280-x.
10
Revisional Bariatric Surgery in Israel: Findings from the Israeli Bariatric Surgery Registry.以色列减重手术的翻修术:以色列减重手术登记处的发现。
Obes Surg. 2019 Nov;29(11):3514-3522. doi: 10.1007/s11695-019-04018-9.